
Abstract 1038: The KIT-V654A second site mutation confers perinatal lethality and increased oncogenesis in a mouse model of GIST
Author(s) -
Jennifer Q. Zhang,
Benedikt Bosbach,
C Antonescu,
Peter Besmer,
Ronald P. DeMatteo
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-1038
Subject(s) - biology , cancer research , cre recombinase , sunitinib , receptor tyrosine kinase , imatinib mesylate , carcinogenesis , microbiology and biotechnology , imatinib , cancer , genetics , receptor , gene , transgene , genetically modified mouse , myeloid leukemia